Ferroptosis and its emerging roles in cardiovascular diseases

N Li, W Jiang, W Wang, R Xiong, X Wu… - Pharmacological Research, 2021 - Elsevier
Ferroptosis is a new form of regulated cell death (RCD) driven by iron-dependent lipid
peroxidation, which is morphologically and mechanistically distinct from other forms of RCD …

[HTML][HTML] Emerging roles of ferroptosis in cardiovascular diseases

K Wang, XZ Chen, YH Wang, XL Cheng, Y Zhao… - Cell death …, 2022 - nature.com
The mechanism of cardiovascular diseases (CVDs) is complex and threatens human health.
Cardiomyocyte death is an important participant in the pathophysiological basis of CVDs …

[HTML][HTML] Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis

Y Baumer, S McCurdy, TM Weatherby… - Nature …, 2017 - nature.com
Endothelial cells (EC) play a key role in atherosclerosis. Although EC are in constant contact
with low density lipoproteins (LDL), how EC process LDL and whether this influences …

[HTML][HTML] CircRNA‑0044073 is upregulated in atherosclerosis and increases the proliferation and invasion of cells by targeting miR‑107

L Shen, Y Hu, J Lou, S Yin… - Molecular …, 2019 - spandidos-publications.com
Circular RNAs (circRNAs) are endogenous non‑coding RNAs implicated in atherosclerosis.
The aim of the present study was to explore the function of circRNA‑0044073 in …

[HTML][HTML] Roles of ferroptosis in cardiovascular diseases

Y Guo, W Zhang, X Zhou, S Zhao, J Wang… - Frontiers in …, 2022 - frontiersin.org
Ferroptosis is an iron-dependent regulated cell death characterized by lipid peroxidation
and iron overload, which is different from other types of programmed cell death, including …

[HTML][HTML] Animal-derived products in science and current alternatives

AC Duarte, EC Costa, HAL Filipe, SM Saraiva… - Biomaterials …, 2023 - Elsevier
More than fifty years after the 3Rs definition and despite the continuous implementation of
regulatory measures, animals continue to be widely used in basic research. Their use …

[HTML][HTML] Extracellular matrix metalloproteinase inducer EMMPRIN (CD147) in cardiovascular disease

SNI von Ungern-Sternberg, A Zernecke… - International journal of …, 2018 - mdpi.com
The receptor EMMPRIN is involved in the development and progression of cardiovascular
diseases and in the pathogenesis of myocardial infarction. There are several binding …

Non-alcoholic fatty liver disease: a metabolic burden promoting atherosclerosis

L Zhang, ZG She, H Li, XJ Zhang - Clinical Science, 2020 - portlandpress.com
Non-alcoholic fatty liver disease (NAFLD) has become the fastest growing chronic liver
disease, with a prevalence of up to 25% worldwide. Individuals with NAFLD have a high risk …

Heteromeric solute carriers: function, structure, pathology and pharmacology

SJ Fairweather, N Shah, S Brӧer - Protein Reviews: Volume 21, 2021 - Springer
Solute carriers form one of three major superfamilies of membrane transporters in humans,
and include uniporters, exchangers and symporters. Following several decades of …

[HTML][HTML] HIF in the heart: development, metabolism, ischemia, and atherosclerosis

AK Knutson, AL Williams, WA Boisvert… - The Journal of …, 2021 - Am Soc Clin Investig
The heart forms early in development and delivers oxygenated blood to the rest of the
embryo. After birth, the heart requires kilograms of ATP each day to support contractility for …